LLY - Latest News

Eli Lilly and Company (LLY), operates in Healthcare / Drug Manufacturers - General, trades on NYSE.

Market capitalization stands near $1.14T. Trailing twelve-month P/E ratio is 42.70. Beta to the broader market is 0.52.

The article list below shows the most recent LLY headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent LLY Headlines

Eli Lilly Hands China Sales Rights for Verzenio to Innovent

gurufocus.com - Jun 30, 2026

Eli Lilly (LLY, Financials) is turning to Innovent Biologics to handle sales of Verzenio in mainland China.

Merck, AbbVie probed by US lawmakers over China clinical trials: report

proactiveinvestors.com - Jun 30, 2026

A bipartisan group of United States lawmakers has opened national security investigations into whether five major pharmaceutical companies, including

Eli Lilly Expands China Cancer Reach

gurufocus.com - Jun 30, 2026

Eli Lilly (LLY) is expanding its China oncology reach through a new commercialization agreement with Innovent Biologics for Verzenios.

Ranking Wall Street's Trillion-Dollar Stocks From Most to Least Attractive, Based on Future Cash Flow

fool.com - Jun 30, 2026

Among Nvidia, Apple, Alphabet, Microsoft, Amazon, Taiwan Semi, SpaceX, Broadcom, Tesla, Meta, Micron, Eli Lilly, and Berkshire Hathaway, there are a h

Forget Weight Loss: Eli Lilly's Real Upside Is As An AI Compounder

seekingalpha.com - Jun 30, 2026

Eli Lilly is leveraging its exceptional cash flow to build an AI-native drug discovery and manufacturing platform, transforming its equity narrative b

How News Affects LLY Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track LLY's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked LLY news questions

What is the latest LLY news headline?

The most recent LLY headline (Jun 30, 2026) is "Eli Lilly Hands China Sales Rights for Verzenio to Innovent". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the LLY news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What LLY news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual LLY options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.